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Abstract: Our aim was to use early magnetic resonance imaging (MRI) to investigate the 
causes of cognitive decline in elderly people with mild cognitive impairment (MCI). Baseline 
structural and ﬂ  ow quantiﬁ  cation MR sequences, and clinical and neuropsychological follow-up 
for at least two years, were performed on 62 elderly subjects with MCI. Of these subjects, 17 
progressed to dementia, and 15 of these progressed to dementia of the Alzheimer type (DAT). 
Conversion to clinically diagnosed DAT was related to six distinct MR proﬁ  les, including 
one proﬁ  le suggesting severe AD (20% of these converters) and ﬁ  ve proﬁ  les suggesting severe 
cerebrovascular dysfunction. Two proﬁ  les suggested arteriosclerotic brain degeneration, one 
proﬁ  le suggested severe venous windkessel dysfunction, and two suggested marked cerebral 
hypoperfusion associated with very low craniospinal compliance or marked brain atrophy. As 
compared with vascular MR type converters, AD MR type converters showed high execu-
tive and mobility predementia performances. Severe whole anteromesial temporal atrophy 
and predominantly left brain atrophy on visual MR analysis was only observed in AD MR 
type converters. In conclusion, these observations enhance the pathogenic complexity of the 
Alzheimer syndrome, and suggest that the role of arteriosclerotic brain degeneration in late life 
dementia is underestimated.
Keywords: Alzheimer’s disease, mild cognitive impairment, dementia, MRI, phase contrast, 
atherosclerosis
Introduction
Dementia of the Alzheimer’s type (DAT), the most common form of late onset 
dementia, is a devastating illness and a growing threat to modern society. We still 
lack a successful disease-modifying therapy, and controversies persist regarding the 
essential causal vascular or primary neurodegenerative process in this late life clinical 
syndrome (Henry-Feugeas 2007a, 2007b).
The commonly used clinical diagnostic criteria of Alzheimer’s disease (AD) do 
not exclude cerebrovascular disease and, indeed, AD and vascular dementia may 
share common clinical features (Henry-Feugeas 2007b). Identifying the exact cause 
of cognitive decline is also complicated by the high frequency of mixed pathology in 
DAT (Neuropathology Group of the Medical Research Council Cognitive Function 
and Ageing Study 2001). Morphological substrates of cognitive impairment result-
ing from cerebrovascular alterations remain controversial (Pantoni et al 2006); in the 
same way, there is no clear neuropathological threshold in late life AD that predicts 
dementia (Prohovnik et al 2006).
Neurodegeneration in AD develops according to a speciﬁ  c sequence with prefer-
ential early and progressively crescent anteromedial temporal atrophy (Halliday et al Clinical Interventions in Aging 2008:3(1) 188
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2003; Braak et al 2006). Unfortunately, AD studies using 
MR frequently focus only on atrophy of a single structure 
of the mesial temporal lobe, most often on atrophy of the 
hippocampus, which is not speciﬁ  c to AD (Henry-Feugeas 
2007a). However, a more extensive structural MR analysis 
of the earliest site of AD, including the entorhinal cortex, 
amygdala, and hippocampus, as well as temporopolar and 
perirhinal regions, can ensure a higher speciﬁ  city for dis-
tinguishing AD from subcortical vascular pathology (Braak 
et al 2006; Du et al 2006).
Phase-contrast MR sequences now allow accurate and 
complete assessment of the intracranial dynamics which may 
help to differentiate AD and vascular cognitive impairment 
(Bateman et al 2006; Henry-Feugeas 2007b). As well as a 
reduction in cerebral arterial inﬂ  ow, alterations in the cru-
cial function required to smooth pulsatile outﬂ  ow from the 
heart are increasingly recognized as another potential cause 
of cerebrovascular dysfunction (O’Rourke and Hashimoto 
2007). This so-called windkessel dysfunction is closely 
dependent on both arterial, venous and cerebrospinal ﬂ  uid 
(CSF) dynamics (Greitz 2004). However, the few studies 
using ﬂ  ow quantiﬁ  cation in elderly patients with cognitive 
decline are most often limited to measurements of arterial 
ﬂ  ow rates or CSF pulsations, and do not take into account the 
particular pattern of regional brain atrophy in AD (Bateman 
et al 2005, 2006; Doepp et al 2006; Bateman and Loiselle 
2007; Vicenzini et al 2007).
Therefore the aim of this longitudinal study was to 
investigate the pathogenic mechanisms of progression to 
dementia, using detailed structural and dynamic MR analysis 
of predementia changes in patients at high risk of AD, that 
is, the elderly with mild cognitive impairment.
Methods
Population and clinical work-up
Between March 2001 and June 2002, 75 community-dwelling 
elderly people were included in a prospective longitudinal 
research study on AD, the Magnetic Resonance Imaging of 
COgnitive DEcline (MRI CODE) study (Onen et al 2004, 
2005; Henry-Feugeas et al 2005; Henry-Feugeas 2007b). 
Subjects were referred to this study as a result of consultations 
at four university hospitals, including four geriatric memory 
consultations and one neurological memory consultation. The 
study was approved by the local medical ethical committee 
and all subjects gave their written informed consent.
French-speaking elderly subjects of at least 60 years 
were included in the study group if they had memory com-
plaints, and low memory and/or attention performance. Low 
memory performance was assessed as at least one error in 
the Mini-Mental State Examination (MMSE) of three word 
recalls. Low attention performance was assessed as a score 
of less than 29 in the Isaac Set test (Isaac and Kennie 1973; 
Folstein et al 1975).
Exclusion criteria were diagnosis of clinical overt dementia 
(as classiﬁ  ed by the consensus of experienced dementia clini-
cians, according to the criteria of the Diagnostic and Statistical 
Manual of Mental Disorders, revised third edition), symptom-
atic cerebrovascular disease or other clinically obvious neuro-
logical conditions, unstable cardiovascular and respiratory or 
neuro-psychiatric diseases. Therefore an MMSE total score 
of less than 25, more than one item impaired at the ﬁ  rst level 
in the four Instrumental Activities of Daily Living (IADL) 
(ability to use the telephone, independent transportation, self 
administration of medication, ability to handle ﬁ  nances), and 
depression as assessed by a score of more than 20 on the 
Montgomery and Asberg depression rating scale, were criteria 
for exclusion (Muller et al 2000). Less than 4 years of formal 
education, age 81 or more at the time of clinical inclusion, or 
absence of an accompanying informant, were also criteria for 
exclusion. A recent routine neuroimaging examination (one 
year or less) was required before inclusion.
Clinical work-up was independently conducted by experi-
enced clinicians and trained neuropsychologists. The baseline 
diagnostic work up included a structured interview with the 
patient and informant, physical examination, routine blood 
tests, and neuropsychological tests. Patients had to be fol-
lowed up by at least an annual neuropsychology test battery 
and clinical assessment. Baseline and follow up neuropsy-
chology tests included the Grober and Buschke, and Trail 
Making Tests (Van der Linden et al 2004; Jokinen et al 2006). 
The executive component in Trail Making Test (TMT) Parts 
A and B was calculated by subtracting the time taken in Part 
A from the time taken in Part B (Jokinen et al 2006).
Mobility was also systematically assessed by one experi-
enced geriatrician as previously described (Onen et al 2004). 
Known causes of mobility disturbance including obesity (body 
mass index 30 kg/m2), musculoskeletal disease, marked 
visual deﬁ  cit, or any medication that could alter mobility func-
tion, were systematically noted. A composite gait and balance 
score was calculated by adding the scores from several tests 
including walking while talking test, timed up and go test, 
standing test, and one leg standing test, and assessment of 
fast gait speed and history of falls. This calculation enabled a 
dichotomic classiﬁ  cation into two groups of patients: those with 
mobility performance score of 1, and those with a mobility 
performance score of 1 (Onen et al 2004).Clinical Interventions in Aging 2008:3(1) 189
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A composite cardiovascular disease risk score integrating 
the presence of arterial hypertension, diabetes, dyslipidemia 
and smoking was also systematically calculated (Whitmer 
et al 2005).
The ﬁ  nal clinical diagnosis of dementia was indepen-
dently made by a panel of experienced dementia clinicians 
using standardized dementia criteria (McKahnn et al 1984; 
Roman et al 1993).
MR evaluation
Acquisition of MR data
All MR examinations were performed on a 1.5 General 
Electric Signa scanner (General Electric Medical System, 
Milwaukee, WI). MR modalities included structural and ﬂ  ow 
quantiﬁ  cation sequences.
A three-dimensional fast spoiled gradient-recalled echo 
sequence was acquired using the following parameters: 124 
contiguous, 1.5 mm-thick images acquired in the coronal plane, 
acquisition matrix = 256 × 256, ﬁ  eld of view 24 cm, repeti-
tion time/echo time = 22/6 ms, ﬂ  ip angle = 35°, and signals 
averaged = 1.24. Contiguous coronal fast FLAIR T2 weighted 
slices 5 mm thick were taken perpendicular to the long axis of 
the hippocampal formation using the following parameters: 
matrix 256 × 192, ﬁ  eld of view 22 cm, time inversion/repetition 
time/effective echo time = 2200/10000 ms/148 ms; and echo 
train length 8 (Onen et al 2004; Henry-Feugeas et al 2005).
Phase-contrast cine sequences (TR 20–23ms; TE 7.6–9.9 
ms; 2 NEX; ﬂ  ip angle 30°; matrix 256 × 256; 2 NEX; 5 
mm thickness; ﬂ  ow compensation) were used to quantify 
the cerebrospinal ﬂ  uid (CSF) and vascular ﬂ  ow through 
the aqueduct and intracranial vessels respectively (Henry-
Feugeas 2007a). Small ﬁ  elds of view of 120 × 120 mm2 and 
140 × 105 mm2 were chosen for aqueductal and vascular 
ﬂ  ow sequences respectively. Using retrospective peripheral 
cardiac gating, 16 quantitative ﬂ  ow-encoded images covering 
the whole cardiac cycle were obtained per plane slice. Direc-
tion of velocity encoding was perpendicular to the acquisition 
plane. Velocity encoding gradient of CSF explorations was 
set at 15 cm/s for CSF acquisition and 80 cm/s for vascular 
acquisitions.
Image analysis and processing
Structural indicators of subcortical vascular 
encephalopathy
The main forms of signiﬁ  cant subcortical vascular encepha-
lopathy in the studied group have been described previously 
(Henry-Feugeas et al 2005). Brieﬂ  y, any form of signiﬁ  cant 
leukoaraiosis was systematically noted. Leukoaraiosis sub-
types included subependymal caps larger than 5 mm around 
the frontal horns, marked changes in the posterior corpus 
callosum or splenial changes, the so-called traumatic or 
periventricular leukoaraiosis, larger or conﬂ  uent changes 
in the deep white or grey matter, the so-called perivascular 
or subcortical leukoaraiosis, white matter changes along 
the optic radiations, or other long-range intrahemispheric 
cortico-cortical connections, the so-called bands leuko-
araiosis.
Structural indicators of Alzheimer type atrophy
The entorhinal cortex surfaces (Sec) were measured using the 
manufacturer’s software Voxtool (General Electric Medical 
System, Milwaukee, WI). The images were aligned to correct 
the undesirable effects of head tilt and rotation. Coronally 
acquired scans were reconstructed into 1.5 mm thick con-
tiguous slices oriented perpendicularly to the long axis of 
the hippocampus. The Sec were manually segmented using 
anatomical landmarks recently proposed in a reproducible 
protocol for outlining the entorhinal cortex in this oblique 
coronal plane (Goncharova et al 2001) and advice from 
Dr. D. Hasboun (personal communication). Brieﬂ  y, a tracing 
of the entorhinal cortex started rostrally where the amygdala 
ﬁ  rst appeared visible, and ended posteriorly in the last slice in 
which the intralimbic gyrus was apparent. The superomedial 
border in rostral sections was the sulcus semi anularis. In 
more caudal sections, when the uncal sulcus was “open”, the 
superomedial border was the inferior border of the subiculum. 
Infero-laterally, the tracing was stopped at the medial edge 
of the collateral sulcus, and on the most anterior sections, the 
lateral branch of the rhinal sulcus when present was used as 
the inferolateral limit of the entorhinal cortex.
All measurements were performed by the same operator 
(MCHF) who was unaware of the ﬁ  nal clinical diagnosis. 
Twenty randomly selected cases were reanalyzed by the 
same operator to assess the intra rater reliability. Intraclass 
correlation coefﬁ  cients were 0.965 for both left and right Sec 
measurements, conﬁ  rming the high reliabilities of entorhinal 
measurements using the previously validated MR sulcal 
hallmarks (Goncharova et al 2001).
Small values on the entorhinal surfaces can result from AD 
as well as from small head size or, especially in the elderly, 
nonspeciﬁ  c global cortical thinning (Capizzano et al 2004 ) or 
brain shrinkage, the end point of various diseases, and there is 
no consensus on the method of normalization of the entorhinal 
cortex (Lye et al 2006). But asymmetric atrophy is highly spe-
ciﬁ  c to primitive neurodegenerative disease (Henry-Feugeas 
2007b). Thus, rather than using a normalization method of Clinical Interventions in Aging 2008:3(1) 190
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uncertain value, an additional index of entorhinal asymmetry 
was calculated according to the formula:
Iec= (left Sec – right Sec)/(left Sec + right Sec)
Visual MR analysis was also systematically performed 
to try to differentiate nonspeciﬁ  c entorhinal atrophy, from 
mesial temporal atrophy of the AD type. As well as a 
high entorhinal index of asymmetry within the two higher 
quartiles, MR indicators of primary neurodegenerative 
disease thus included visual evidence of predominantly 
left mesial temporal atrophy, ventricular enlargement, and 
visual evidence of marked atrophy of the AD type. This last 
pattern was deﬁ  ned as MR evidence of disproportionate 
enlargement of the rhinal/collateral sulcus, the hallmark of 
early damage to the surrounding entorhinal and perirhinal 
cortices in AD, marked atrophy of the amygdalo hippo-
campal region, and temporal poles at least on the left side 
(Figure 1).
Nonspeciﬁ  c structural parameters
Marked ventriculomegaly and marked enlargement of the 
sulci were deﬁ  ned as a grade of 6 or more on the American 
Cardiovascular Health Study classiﬁ  cations (Onen et al 
2004, 2005). Marked global brain shrinkage was deﬁ  ned by 
the cluster pattern of marked enlargement of the ventricles 
and marked enlargement of the convexity sulci and the 
interhemispheric scissure.
Hemodynamic and hydrodynamic parameters
Vessel conduit function: Flow through the basilar artery 
and the cavernous portion of the internal carotid arteries was 
studied using a section plane approximately perpendicular 
to these vessels (Bateman and Loiselle 2007). This scan 
also allowed the assessment of ﬂ  ow through the straight 
sinus and the superior longitudinal sinus. Regions of interest 
(ROI) were manually drawn, outlining the vascular struc-
tures on the phase images. Background ROI were placed 
in the adjacent brainstem to correct arterial ﬂ  ow velocities, 
and in the adjacent occipital parenchyma to correct venous 
ﬂ  ow velocities. Using a commercial ﬂ  ow analysis package 
(CV ﬂ  ow; General Electric Medical System, Milwaukee, 
WI), blood ﬂ  ow waveforms during the cardiac cycle curves 
could be demonstrated. For each of the 16 time frames, the 
product of the mean velocity and the corresponding ROI 
area provided an estimate of the volume ﬂ  ow rate through 
the structures studied (Onen et al 2005). The measurements 
enabled these parameters to be determined: determination of 
the total supratentorial cerebral blood ﬂ  ow (TCBF) as the sum 
of ﬂ  ow through both internal carotid arteries and the basilar 
artery; superﬁ  cial and deep venous outﬂ  ow respectively from 
the superior sagittal sinus and the straight sinus.
Windkessel function: The index of arterial pulsatility (IP) 
was calculated by subtracting the end diastolic from the peak 
systolic ﬂ  ow and dividing by the mean ﬂ  ow (Gosling et al 
1991). The amplitudes of intracranial blood and cerebrospinal 
ﬂ  uid (CSF) pulsations were also directly assessed. Net intra-
cranial blood ﬂ  ow was calculated after scaling total arterial 
inﬂ  ow until it equalled the venous outﬂ  ow, by subtraction of 
the venous outﬂ  ow measure at each time frame of the cardiac 
cycle from the corresponding arterial inﬂ  ow measure. CSF and 
net blood stroke volumes were thus calculated similarly from 
sinusoidal ﬂ  ow waveforms, deﬁ  ning the volumes of CSF and 
blood pulsations per minute, respectively (Onen et al 2005).
The index or compliance ratio, an indicator of craniospinal 
compliance (Bateman et al 2005; Bateman and Loiselle 2007), 
was calculated as follows: the aqueduct stroke volume was sub-
stracted from the blood pulse to obtain the volume of ﬂ  uid to be 
dissipated outside the ventricles through the subarachnoid space 
which was then divided by the aqueduct stroke volume.
Data analysis
Converters subtype MR classiﬁ  cation
Baseline entorhinal measurements and dynamic MR param-
eters in all the MCI patients with both high quality three 
dimensional MRI and complete dynamic available examina-
tion (n = 71) were categorized into quartiles. This exercise 
allowed a preliminary MCI classiﬁ  cation into these (nonex-
clusive) categories: possible AD, possible cerebrovascular 
dysfunction including the subtypes of low vascular windkes-
sel effect, low craniospinal compliance, and decrease in 
cerebral blood ﬂ  ow rates (Table 1). MR features of converters 
and nonconverters classiﬁ  ed into the same MR category were 
then compared, to identify additional MR criteria of conver-
sion and deﬁ  ne MR predementia proﬁ  les.
Clinical validity of converters MR classiﬁ  cation
Key clinical and routine MR parameters were compared 
between converters corresponding to the MR criteria of 
advanced AD, or AD MR type converters, and converters 
which did not respond to these criteria. Key clinical param-
eters included worst predementia executive and anterograde 
verbal memory performances. Mobility scores were also 
analyzed in converters with no known cause of mobility 
disturbances. Clinical parameters thus included the worst 
predementia delayed verbal memory scores on the Grober 
and Bushke test, the worst predementia executive scores on 
the TMT (time to perform part B – time to perform part A) Clinical Interventions in Aging 2008:3(1) 191
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test, and baseline composite mobility scores. Potential bias 
that may be associated with age, level of education, total 
scores on the baseline MiniMental State Examination 
(MMSE), time to conversion; and vascular risk factor 
scores were also researched. Conventional MR parameters 
included periventricular and subcortical leukoaraiosis, visual 
evidence of severe AD type mesiotemporal atrophy, and of 
predominantly left mesiotemporal and ventricular atrophy. 
Statistical differences between groups were analyzed using 
the Mann–Whitney U-test or Fisher’s Exact Test according 
to the nature of the variables.
Results
Structured clinical follow-up until the onset of dementia or 
for a period of at least 2 years was obtained for 62 patients 
(mean age 72 ± 6 years). Of these patients, 15 progressed to 
DAT; two developed a clinical picture of vascular dementia. 
The main clinical and neuropsychological features of the 
subjects divided for ﬁ  nal clinical diagnosis and for baseline 
MR characteristics (non-AD or AD type, responding or not 
to MR criteria of conversion) are summarized in Tables 2 
and 3 respectively.
Converters subtype MR classiﬁ  cation
The baseline distributions of the quantitative structural and 
dynamic characteristics of the initial study group, used to 
determine speciﬁ  c MR subtypes, are summarized in Table 4. 
MR features that enabled baseline separation of converters 
and nonconverters within each category are summarized in 
Table 1. These predementia MR proﬁ  les were observed in 
Figure 1 Mesiotemporal atrophy in the AD MR class of converters to dementia of the Alzheimer type. These oblique coronal reformatted T1-weighted images at the level of 
the anterior parahippocampal gyri are from a nonconverter (A) and three AD MR type converters (B, C and D), respectively 41 (B), 17 (C) and 11 (D) months before diagnosis 
of dementia. Compared with the nonconverter, these converters showed predominantly left mesial temporal atrophy and ventricular enlargement and marked atrophy of the 
AD type; there was a marked dilatation of the left rhinal sulcus (long arrows) and concave superior border of the anterior amygdala region (short arrows).
A B
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the 17 patients who progressed to dementia during clinical 
follow up. Thus, all the converters showed a predementia 
MR proﬁ  le (Table 5). Conversely, these predementia MR 
proﬁ  les were not observed in the 45 non-converters nor in 
the remaining 9 patients who had a clinical follow up of less 
than 2 years.
The MR class of AD type converters could be differenti-
ated from stable MCI patients and other converters on the basis 
of marked bilateral entorhinal atrophy, suggesting advanced 
AD (Table 1). Progression to dementia in this category also 
required low intracranial blood pulsations (Table 1).
This cluster pattern of bilateral marked entorhinal atrophy 
and low blood stroke was associated with entorhinal indices 
of asymmetry within the two highest quartiles. Conversely, 
marked reduction in cerebral blood ﬂ  ow appeared inconstant; 
superﬁ  cial venous outﬂ  ow was within the two highest quartiles 
in each of these converters. One of these converters even had 
high TCBF which was within the highest quartile. None of 
these converters showed the complete predementia MR pat-
tern of windkessel dysfunction, although all showed at least 
one pattern of low windkessel function; very high IP (highest 
quartile) and low compliance ratio (lower quartile) in one case, 
high IP (higher quartile) in another case, or very low compli-
ance ratio (lowest quartile) in the last case. The so-called bands 
were also detected at least along the optic radiations in two 
of these converters.
The class of non-AD MR type converters was the 
largest class of converters (Tables 1 and 5). There was 
inconstant reduction in entorhinal measurements and 
variable entorhinal indices of asymmetry in this class. 
Table 1 Classiﬁ  cation of MR proﬁ  les
Baseline MR category Baseline MR criteria predicting conversion
Possible AD (n = 34) Advanced AD subtype (n = 3)
Entorhinal cortex value within the two lowest quartiles at least on 
the left side
Left and right entorhinal values within the lowest quartile without 
any signiﬁ  cant subcortical nor periventricular white matter changes*
+ blood stroke within the two lowest quartiles
Other predementia MR proﬁ  les (n = 8)
Possible cerebrovascular dysfunction
Low arterial windkessel effect (n = 18)
IP and blood stroke values
Within the two highest quartiles
Microangiopathy subtype (n = 6)
Subcortical and periventricular white matter changes*
+ TCBF outside the highest quartile
Marked cortical thinning subtype (n = 1)
Left and right entorhinal values within the lowest quartile 
+ superﬁ  cial venous outﬂ  ow within the two lowest quartiles
Windkessel dysfunction not related to the large arteries 
(n = 14)
Blood stroke value within the two highest quartiles IP outside the 
two highest quartiles
Venous subtype (n = 1)
Subcortical and periventricular white matter changes* 
+ deep venous ﬂ  ow within the two lowest quartiles despite 
TCBF within the two highest quartiles
Low cortical perfusion (n = 23)
Arterial and superﬁ  cial venous ﬂ  ow rates within the two lowest 
quartiles
Very low craniospinal compliance subtype (n = 3)
TCBF within the lowest quartile
+ compliance ratio within the lowest quartile
Nonspeciﬁ  c severe brain atrophy subtype (n = 3)
TCBF within the lowest quartile
+ marked widening of the sulci or
+ superﬁ  cial and deep venous outﬂ  ow, blood and CSF strokes within 
the lowest quartile
Other predementia MR proﬁ  les (n = 3)
Notes: The term “subcortical white matter changes” indicates larger perivascular deep white matter changes; the term “periventricular white matter changes” indicates 
larger subependymal changes or marked splenial changes. The term “other predementia MR proﬁ  les” refers to one or more of the previously deﬁ  ned predementia MR 
proﬁ  les; advanced AD subtype, microangiopathy subtype, marked cortical thinning subtype, venous subtype, very low craniospinal compliance subtype, or nonspeciﬁ  c severe 
brain atrophy subtype.
Abbreviations: IP, index of arterial pulsatility; TCBF, total supratentorial cerebral blood ﬂ  ow; CSF, cerebrospinal ﬂ  uid.Clinical Interventions in Aging 2008:3(1) 193
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However, all these converters could be differentiated from 
stable MCI patients by MR patterns suggestive of severe 
vascular disturbances, that is, marked vascular windkessel 
dysfunction, marked cerebral hypoperfusion associated 
with very low craniospinal compliance or marked brain 
atrophy (Table 1).
As expected, the predementia MR subtype of very low 
craniospinal compliance was characterized by high CSF 
stroke (within the two higher quartiles), whereas very low 
TCBF contrasted with high entorhinal values and lack of 
marked enlargement of the sulci in this subtype.
However, conﬂ  uent white matter changes affected only 
4 (29%) of these vascular MR type converters. In addition, 
bands at least along the optic radiations were detected in ten 
(71%) of these converters.
The so-called resistive MR pattern, a predementia vascular 
MR pattern characterized by MR evidence of severe reduction 
in craniospinal compliance, was associated with a ﬁ  nal clinical 
diagnosis of both DAT (n = 1) and vascular dementia (n = 2). 
Thus, the single ﬁ  nal clinical diagnosis of DAT made in 15 
converters appeared to be related to six distinct predementia 
MR subtypes, whereas the MR pattern of advanced AD was 
observed in only 20% of these converters.
Clinical and conventional key MR features 
of vascular and AD MR type converters
Vascular and AD MR type converters did not show sig-
niﬁ  cant differences in age (75 ± 4 and 78 ± 2 years respec-
tively), vascular risk factor scores (range 0–4 versus 1–4, 
respectively), MMSE scores (range 25–29 versus 26–27, 
respectively), time to conversion (23 ± 16 months and 
17 ± 9 months, respectively), years of schooling (12 ± 3 and 
10 ± 6 years, respectively), or predementia delayed total 
recall scores based on the Grober and Buschke test (range 
0–16 versus 5–8, respectively).
Conversely, there was no overlap in the worst predemen-
tia executive scores between these two groups of converters; 
the worst predementia substraction score on the TMT was 
equal to or below 60 seconds in AD MR type convert-
ers, whereas this score was equal to or above 65 seconds 
Table 2 Demographic and clinical baseline characteristics 
according to ﬁ  nal clinical diagnosis
Baseline Nonconverters Converters
variables (n = 45) (n = 17)
Age 71 ± 6 75 ± 4
Females/males 10/7 28/17
Years of schooling 12 ± 4 11 ± 4
Cardiovascular risk score 1 ± 11  ± 1
MMSE (total score) 28 ± 1 27 ± 1
Grober and Buschke test, 
DTR score
15 ± 1 11 ± 5
Trail making test, substraction 
score
82 ± 65 129 ± 91
Mobility scores 1.6 ± 1.6* 3.1 ± 2*
Notes: *Mobility scores are only reported in patients without known cause of 
mobility dysfunction (15 converters and 40 nonconverters).
Abbreviations: MMSE, MiniMental State Examination; DTR, delayed total recall 
score.
Table 3 Demographic and clinical baseline characteristics according to baseline MR subtypes (non-AD or AD type, responding or not 
to MR criteria of conversion)
Baseline clinical variables Baseline MR proﬁ  les*
Possible 
AD (non-converters)
AD predementia
(converters)
Possible cerebrovascular 
dysfunction
(non-converters)
Non-AD predementia 
(converters)
Age 73 ± 7 78 ± 2 68 ± 5 75 ± 5
Females/males 2/2 0/3 11/3 3/3
Years of schooling 16 ± 3 10 ± 6 13 ± 4 13 ± 5
Cardiovascular risk score 1 ± 12  ± 11  ± 11  ± 1
MMSE total score 27 ± 1 27 ± 1 28 ± 1 28 ± 1
Grober-Buschke test, DTR score 14 ± 1 12 ± 5 16 ± 1 14 ± 3
Trail Making Test, substraction score 97 ± 45 36 ± 6 64 ± 35 130 ± 92
Mobility scores** 0 ± 11  ± 02  ± 24  ± 2
Notes: *Patients with “mixed” MR presentations characterized by coexistence of MR proﬁ  les of at least possible AD and possible cerebrovascular are not included in these 
subgroups; **mobility scores are presented only in patients with no known cause of mobility (2 of the 4 patients with pure possible AD MR proﬁ  le, all the 3 patients with 
pure AD predementia MR proﬁ  les, all the 14 patients with MR proﬁ  le of possible pure cerebrovascular dysfunction, and all the 6 patients with pure predementia non-AD 
proﬁ  les).
Abbreviations: MMSE, MiniMental State Examination; DTR, delayed total recall score.Clinical Interventions in Aging 2008:3(1) 194
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in vascular MR type converters (52 ± 10 and 181 ± 85, 
p = 0.009). Moreover, among the 15 converters with no evi-
dent cause of mobility dysfunction, each of the three AD MR 
type converters showed high mobility scores, whereas 93% 
of the vascular MR type converters obtained low mobility 
scores (p = 0.006).
None of the AD MR type converters showed any signiﬁ  -
cant classical form of leukoaraiosis including periventricular 
and subcortical leukoaraiosis; conversely, signiﬁ  cant deep 
white matter changes were present in 10 (71%) of the vascu-
lar MR type converters (p = 0.05). Finally, all the AD type 
converters but none of the vascular type converters presented 
visual evidence of marked atrophy of the AD type (p = 0.001), 
MR evidence of predominantly left ventricular enlargement, 
and mesiotemporal atrophy (p = 0.001) (Figures 1 and 2).
Discussion
This prospective study on cognitive decline indicated that 
conversion to clinically diagnosed DAT was associated 
with six distinct MR patterns in the elderly with MCI; one 
MR proﬁ  le suggestive of advanced AD (observed in only 
20% of these converters) and ﬁ  ve MR proﬁ  les suggestive of 
severe cerebrovascular dysfunction. This MR classiﬁ  cation 
was supported by distinct clinical patterns in AD and 
vascular MR type converters, which mirrored traditional 
clinical differences between early-onset AD and vascular 
dementia. These data enhanced the complex etiopathogeny 
of late onset dementia, particularly the over-estimated 
contribution of AD and under-recognized contribution 
of cerebrovascular dysfunction to late dementia of the 
Alzheimer’s type.
The MR classiﬁ  cation of converters
Disturbances in capillary exchanges appeared to be the ﬁ  nal 
common consequence of the non-AD MR patterns, which 
were associated with progression to dementia in our MCI 
patients, as a result of marked vascular windkessel dysfunc-
tion or decrease in cerebral blood ﬂ  ow rates.
The vascular MR type of converters
The predementia pattern of arterial windkessel dysfunction 
appeared consistent with the historical concept of arterio-
sclerotic dementia (Roman 1999). Indeed, high IP may be 
considered a biomarker of advanced large artery stiffness 
and its logical consequence, cerebral small vessel disease 
(Roher et al 2006; O’Rourke and Hashimoto 2007). Loss of 
compliance in large conduit atherosclerotic arteries widens 
the amplitude of intracranial blood pulsations (Hirata et al 
2006). Thus, “hardening of the arteries” is a good explana-
tion of the dynamic cluster pattern of high IP and amplitude 
of cerebral blood pulsations in the MR category of arterial 
windkessel dysfunction.
Leukoaraiosis is the main neuropathological substra-
tum of chronic progressive subcortical encephalitis, a 
neuropathological substratum of arteriosclerotic dementia 
(Roman 1999). This may contribute to its value as the 
most common structural criteria of conversion, in line with 
growing evidence of its association with cognitive decline 
(Debette et al 2007). Similarly, senile cortical atrophy is 
another neuropathological substratum of arteriosclerotic 
dementia (Roman 1999), whereas marked cortical thinning 
was the alternative structural criteria of conversion in the 
arterial windkessel dysfunction MR subtype in our study. 
Superﬁ  cial venous outﬂ  ow is linearly correlated with cerebral 
cortical ﬂ  ow (Inao et al 1997), and functional evidence of 
global cortical hypometabolism, as assessed by low superﬁ  -
cial venous outﬂ  ow, was also required to progress to dementia 
in this MR category.
In MCI patients with MR evidence of high blood pulsa-
tions but no elevated arterial index of pulsatility, progres-
sion to dementia required impaired venous outﬂ  ow and MR 
evidence of leukoaraiosis. Indeed, experimental studies have 
shown increased arterial pulse in cases of impaired venous 
outﬂ  ow and, as well as the part played by large arteries, 
there is also a venous contribution to the vital function of 
Table 4 Baseline MR characteristics of study sample
Baseline variables Range (25th percentile/
median/75th percentile)
Left entorhinal measurements 
(mm2)
209 to 692 (394/438/502)
Right entorhinal 
measurements (mm2)
299 to 585 (395/437/502)
Index of entorhinal asymmetry −16 to 26 (−4.72/0.85/4.61)
Total cerebral blood ﬂ  ow 
(TCBF, mL/min)
511 to 1219 (654/752/844)
Deep venous outﬂ  ow 
(mL/min)
64 to 188 (93/119/139)
Superﬁ  cial venous outﬂ  ow 
(mL/min)
121 to 426 (240/281/322)
Index of arterial pulsatility (IP) 0.78 to 1.67(0,99/1,08 / 1, 25)
Blood stroke per min (mL) 48 to 179 (74/90/106)
Cerebrospinal ﬂ  uid stroke 
per min (mL)
0.67 to 10,37 (3.2/4.20/5.9)
Relative craniospinal 
compliance
5 to 131 (15/20/29)Clinical Interventions in Aging 2008:3(1) 195
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Table 5 Distribution of MR proﬁ  les according to ﬁ  nal clinical diagnosis
MR changes N Predementia MR proﬁ  les MR classiﬁ  cation Final clinical diagnosis
Isolated possible AD (A) 4 absent not pre-dementia not demented
3 advanced AD advanced AD DAT
Isolated low arterial windkessel 
effect (B)
3 absent not predementia not demented
2 microangiopathy VD/severe arterioscl. brain 
degeneration
DAT
Isolated low nonarterial windkessel 
effect (C)
5 absent not predementia not demented
Isolated low cortical perfusion (D) 4 absent not predementia not demented
1 nonspeciﬁ  c severe brain 
atrophy
nonspeciﬁ  c severe brain atrophy DAT
1 very low craniosp. compliance VD/ severely restricted brain perf. DAT
2 very low craniosp. compliance VD/severely restricted brain perf. VaD
(A) + (B) 5 absent not predementia not demented
1 microangiopathy VD/severe arterioscl. brain 
degeneration
DAT
1 marked cortical thinning VD/severe arterioscl. brain 
degeneration
DAT
(A) + (C) 7 absent not pre-dementia not demented
1 venous subtype VD/venous cognitive impairment DAT
(A) + (D) 5 absent not pre-dementia not demented
2 nonspeciﬁ  c severe brain 
atrophy
nonspeciﬁ  c severe brain atrophy DAT
(B) + (D) 1 absent not predementia not demented
(C) + (D) 1 absent not predementia not demented
(A) + (B) + (D) 2 absent not predementia not demented
3 microangiopathy VD/severe arterioscl. brain 
degeneration
DAT
Absence of (A), (B), (C) or (D) 8 absent not pre-dementia not demented
Abbreviations: AD, Alzheimer’s disease;  VD, cerebrovascular disease; DAT, dementia of the Alzheimer type;  VaD, vascular dementia; craniospin, craniospinal; arterioscl, 
arteriosclerotic; perf., perfusion.
buffering pulsatile outﬂ  ow from the heart (Baumbach 1996). 
Leukoencephalopathy related to vasogenic edema is also an 
indicator of severely impaired venous outﬂ  ow (Kawaguchi 
et al 2001). Such a venous windkessel dysfunction as a pos-
sible cause of dementia also appears to be consistent with 
clinical evidence of dural arteriovenous ﬁ  stula as a cause of 
slowly progressing dementia (Waragai et al 2006). The exact 
pathogenesis of impaired deep venous outﬂ  ow needs to be 
determined in otherwise healthy elderly with MCI, but deep 
venous collagenosis, disturbances in the pulsatile displace-
ment of the central part of the brain closely related to the deep 
venous system, and increased venous pressure with aging 
may all contribute to venous windkessel dysfunction in the 
elderly (Moody et al 1995; Henry-Feugeas et al 2005).
The predementia proﬁ  les based on MR evidence of brain 
atrophy also required both structural and functional criteria. 
Hypometabolism is coupled with decreased perfusion, 
whereas marked widening of sulci may coexist with relatively 
preserved cognition (Mosley et al 2005). This may explain 
the importance of dynamic evaluation of brain perfusion in 
this MR subtype.
Finally, all the MR criteria that deﬁ  ned the predementia 
pattern of low craniospinal compliance converged to suggest 
a severe reduction in the craniospinal compliance. Indeed, 
this pattern required as expected a compliance ratio within the 
lowest quartile (Bateman et al 2005; Bateman and Loiselle 
2007). The very low intracranial blood ﬂ  ow rates in this 
MR category contrasted with high entorhinal values and 
lack of marked enlargement of the sulci; it thus suggested 
a forced restriction in the intracranial expansion of the vas-
cular compartment, rather than severe brain atrophy (Greitz 
2004). High CSF stroke amplitude and reduced superﬁ  cial Clinical Interventions in Aging 2008:3(1) 196
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Figure 2 Mesiotemporal atrophy in the vascular MR class of converters to dementia of the Alzheimer type. These oblique coronal reformatted T1-weighted images at the level 
of the anterior parahippocampal gyri are from ﬁ  ve vascular type converters; one with arterial windkessel dysfunction and cerebral microangiopathy 9 months before diagnosis 
of dementia (A), one with arterial windkessel dysfunction and marked cortical atrophy 33 months before diagnosis of dementia (B), one with venous windkessel dysfunction 
12 months before the diagnosis of dementia (C), one with resistive MR subtype 24 months before diagnosis of dementia (D), and the last one with a MR pattern of global 
cerebral hypoperfusion 13 months before diagnosis of dementia (E). There is no disproportionate enlargement of the left rhinal sulcus (long arrows), no marked concavity of 
the upper limit of the left amygdala region (short arrows), nor marked evidence of left predominance of brain atrophy.
B
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venous outﬂ  ow rate are also known deleterious effects of 
reduced craniospinal compliance (Henry-Feugeas et al 2001; 
de Marco et al 2004).
The AD MR type of converters
The degree of atrophy in the medial temporal structures is 
related to global disease extent in AD (Hallyday et al 2003), 
whereas reduction in cerebral perfusion is most often not 
diffuse in the early AD stages. This may explain that marked 
bilateral entorhinal atrophy, rather than marked reduction in 
cerebral blood ﬂ  ow, is required to progress to dementia in 
the AD MR subtype.
Lack of noticeable elevation in intracranial blood pulsa-
tions in these converters contrasted with high intracranial blood 
pulsations in converters with marked vascular windkessel 
dysfunction. This result supports the recent observation that 
AD and vascular dementia may show opposite dynamic fea-
tures (Bateman et al 2006). AD MR type converters, however, 
showed some degree of windkessel dysfunction, consistent 
with the view that AD is a chronic form of pulse wave encepha-
lopathy, with less severe windkessel dysfunction but a longer 
time frame than other forms of pulse wave encephalopathy, 
such as vascular dementia (Bateman and Loiselle 2007).
The associated clinical and “routine” MR proﬁ  les
The clinical proﬁ  le of the AD MR type converters appeared 
consistent with the deﬁ  nition of AD as a primarily cognitive 
disorder with only delayed motor dysfunction, but early and 
marked anterograde episodic memory related to left entorhinal 
dysfunction (McKann et al 1984; Eustache et al 2001).
The clinical proﬁ  le of the non-AD MR type converters 
was characterized by a heterogeneous pattern of forgetting 
but consistently lower executive and mobility performances. 
These clinical features thus converged with “routine” MR 
features to suggest a causal subcortical cerebrovascular dys-
function in this preponderant prodromal form of late onset 
DAT (Jokinen et al 2006; Zanetti et al 2006).
Indeed, high frequency of leukoaraiosis in vascular MR 
type converters paralleled high frequency of leukoaraiosis in 
MCI patients with multiple impaired cognitive domains and 
motor decline (Onen et al 2004; Bell-McGinty et al 2005; 
Zanetti et al 2006). AD MR type converters showed predomi-
nantly left atrophy but lacked signiﬁ  cant periventricular or 
subcortical leukoaraiosis; these observations also appeared 
consistent with previous MR studies of early-onset AD and 
“pure” amnestic MCI, both forms the most closely related to 
AD in clinico-pathological correlations (Bell-McGinty et al 
2005; Henry-Feugeas 2007b).
Finally, each converter that lacked visual baseline 
evidence of marked atrophy of the whole anteromesial tem-
poral regions showed MR evidence of severe cerebrovascular 
dysfunction. This appeared in line with neuropathological 
evidence of advanced AD – and thus severe neuronal loss 
and atrophy at least in the earliest sites of AD, before the 
onset of dementia or even moderate cognitive impairment 
(Bennett et al 2006; Henry-Feugeas 2007b).
The heterogeneous Alzheimer’s 
syndrome
Both AD and vascular MR type converters progressed to 
DAT, whereas one vascular MR proﬁ  le predicted both DAT 
and vascular dementia. Such a clinical overlap between 
severe cerebrovascular dysfunction and advanced AD may 
explain that DAT and vascular dementia share similar pro-
dromal clinical pictures (Henry-Feugeas et al 2007b).
The most frequent prodromal MR pattern of DAT, with 
MR evidence of only mild or moderate AD type atrophy and 
frequent leukoaraiosis, also appeared consistent with the most 
frequent neuropathological pattern of late onset DAT, with 
only mild extent AD lesions incapable of causing dementia 
in themselves but high frequency of cerebrovascular lesions. 
Thus, only 20% of converters with a ﬁ  nal diagnosis of DAT 
showed an MR pattern of advanced AD, in good agreement 
with 19% of pure AD in the Honolulu Asia study, 21% in 
the British Medical Research Council Study on Cognitive 
Function and Ageing, and 20%–30% in the Einstein Aging 
study (Henry-Feugeas 2007b).
Finally, the lack of prominent physical brain lesions in 
several predementia MR patterns may contribute to persis-
tent difﬁ  culties in the neuropathological diagnosis of late life 
dementia (Neuropathology Group of the Medical Research 
Council Cognitive Function and Ageing Study 2001), whereas 
all these data enhance the importance of functional criteria in 
the diagnosis of cerebrovascular dysfunction.
In conclusion, these still preliminary results highlight the 
devastating effect of the age-related stiffening of the large 
arteries in late life dementia, thus supporting the historical 
description of senile dementia as mainly an arteriosclerotic 
dementia. The results suggest that using both structural and 
functional MR analysis to investigate the Alzheimer syn-
drome could allow more targeted therapeutic research on 
late-onset dementia.
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